Literature DB >> 6701460

Non-transferrin plasma iron in beta-thalassaemia/Hb E and haemoglobin H diseases.

M Anuwatanakulchai, P Pootrakul, P Thuvasethakul, P Wasi.   

Abstract

Non-transferrin plasma iron concentrations were determined in 45 normal controls and in 37 patients with Hb H disease and 104 patients with beta-thalassaemia/Hb E disease. This revealed that non-transferrin plasma iron exists in cases with severe iron overload, more striking in beta-thalassaemia/Hb E than in Hb H disease. Non-transferrin plasma iron is associated with higher transferrin iron saturation and higher plasma ferritin levels. The most striking finding was the significantly higher non-transferrin plasma iron in splenectomized patients with beta-thalassaemia/Hb E disease than in the non-splenectomized patients. In view of the potential toxicity of non-transferrin iron, this fraction of iron may be responsible for tissue damage in these patients especially after splenectomy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6701460     DOI: 10.1111/j.1600-0609.1984.tb02171.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  6 in total

Review 1.  Iron and infection.

Authors:  C Hershko; T E Peto; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

2.  Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.

Authors:  Y Waterlot; B Cantinieaux; C Hariga-Muller; E De Maertelaere-Laurent; J L Vanherweghem; P Fondu
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-24

3.  Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients.

Authors:  Ali T Taher; John B Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Dany Habr; Jacqueline Ros; Yiyun Zhang; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-05-13       Impact factor: 10.047

4.  Glutathione redox system in β -thalassemia/Hb E patients.

Authors:  Ruchaneekorn W Kalpravidh; Thongchai Tangjaidee; Suneerat Hatairaktham; Ratiya Charoensakdi; Narumol Panichkul; Noppadol Siritanaratkul; Suthat Fucharoen
Journal:  ScientificWorldJournal       Date:  2013-10-07

Review 5.  When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.

Authors:  A T Taher; A Radwan; V Viprakasit
Journal:  Vox Sang       Date:  2014-10-07       Impact factor: 2.144

Review 6.  The (Bio)Chemistry of Non-Transferrin-Bound Iron.

Authors:  André M N Silva; Maria Rangel
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.